You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 5, May 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Men's Health
 •Men's Health, Other
 •Oncology
 •Head & Neck Cancer
 •Dermatology
 •Neoplasms of Head & Neck
 •Melanoma
 •Prognosis/ Outcomes
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Epidemiological Features and Prognostic Factors of Cutaneous Head and Neck Melanoma

A Population-Based Study

Alexander Golger, MD; Diana S. Young, BSc; Danny Ghazarian, PhD; Peter C. Neligan, MB

Arch Otolaryngol Head Neck Surg. 2007;133(5):442-447.

Objectives  To describe the epidemiological features of cutaneous head and neck melanoma (CHNM) and to identify factors associated with mortality from this disease.

Design  A population-based cohort study.

Setting  Patients treated for CHNM in Ontario between January 1, 1994, and December 31, 2002, were identified through the provincial Cancer Registry. A Cox proportional hazards regression model was used to analyze the data.

Patients  A total of 2218 patients with CHNM were identified, comprising 15.8% of all melanomas in Ontario. The mean age of the cohort was 66 years (SD, 16 years); 1363 patients (61.5%) were males.

Main Outcome Measure  Patients' vital status (dead or alive).

Results  The incidence of CHNM increased from 2.0 per 100 000 in 1996 to 2.7 per 100 000 in 2001, while mortality remained stable. The Cox proportional hazards regression model showed that increased age (hazard ratio [HR], 1.06; 95% confidence interval [CI], 1.04-1.06) and male sex (HR, 1.31; 95% CI, 1.03-1.66) had a significantly higher risk of death. Patients with lesions of the scalp and neck had a 53% higher risk of death than those with lesions of the face. Nodular melanoma (HR, 1.61; 95% CI, 1.17-2.24) had the worst prognosis compared with other morphological types. Increased tumor thickness (HR, 1.05; 95% CI, 1.03-1.07), ulceration (HR, 1.53; 95% CI, 1.08-2.07), and Clark level V (HR, 1.52; 95% CI, 1.01-2.22) were significantly associated with increased mortality.

Conclusions  Our study demonstrated an increase in the incidence of CHNM. Advanced age, male sex, nodular morphological features, tumor thickness, ulceration, and Clark level V carried a significant risk of death, whereas facial melanomas had a favorable prognosis.


Author Affiliations: Division of Plastic Surgery, Department of Surgery, University of Toronto (Drs Golger and Neligan and Ms Young), and Department of Pathology, Princess Margaret Hospital, University Health Network (Dr Ghazarian), Toronto, Ontario.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck
Carol R. Bradford and Paul A. Levine
JAMA. 2007;297(23):2628-2629.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Melanoma of the scalp and neck had greater risk of melanoma-specific mortality than melanoma of the extremities
McCarthy
Evid. Based Med. 2008;13:155-155.
FULL TEXT  

Shedding of Distinct Cryptic Collagen Epitope (HU177) in Sera of Melanoma Patients
Ng et al.
Clin. Cancer Res. 2008;14:6253-6258.
ABSTRACT | FULL TEXT  

Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program
Lachiewicz et al.
Arch Dermatol 2008;144:515-521.
ABSTRACT | FULL TEXT  

Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck
Bradford and Levine
JAMA 2007;297:2628-2629.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.